2025-2034 STD Diagnostics Market Roadmap: Insights for Competitive Advantage

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the STD Diagnostics Market Size By 2025?
The market size for STD diagnostics has experienced significant growth in the past few years. Its size is expected to increase from $9.93 billion in 2024 to $10.77 billion in 2025, signifying a compound annual growth rate (CAGR) of 8.5%. Factors contributing to the growth in the past years include epidemiological trends, enhancements in healthcare infrastructure, advancements in pharmaceuticals, implementation of sexual education programs, and demographic changes.

How Big Is the STD Diagnostics Market Size Expected to Grow by 2029?
In the coming years, the std diagnostics market is projected to experience swift expansion, culminating in a value of $15.98 billion in 2029, representing a compound annual growth rate (CAGR) of 10.4%. The surge during the projection period can be explained by influences such as tailored medicine trends, enhanced healthcare accessibility, population health plans, telemedicine plus digital health, and an escalating prevalence of STDs. The forecast period is predicted to be characterized by aspects like point-of-care testing (POCT) advancements, home testing kits, multiplex examinations, targeted marketing and outreach strategies, pre-exposure prophylaxis (prep) programs, and climbing incidence figures.

View the full report here:
https://www.thebusinessresearchcompany.com/report/std-diagnostics-global-market-report

Which Key Market Drivers Powering STD Diagnostics Market Expansion and Growth?
The increase in sexually transmitted diseases (STDs) is propelling growth in the STD diagnostics market. STDs are contagious infections that spread between individuals primarily through sexual interaction. STD diagnostics allow for effective detection and evaluation of these infections. For example, in 2022, the World Health Organization (WHO), a United Nations international health agency geared towards enhancing global public health, reported that globally, over a million sexually transmitted infections are contracted daily. Furthermore, there's an annual estimate of around 374 million fresh instances, with one in four STDs being chlamydia, gonorrhea, syphilis, or trichomoniasis. Consequently, the escalating incidence of STDs is driving the expansion of the STD diagnostics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8507&type=smp

Which Emerging Trends Are Transforming the STD Diagnostics Market in 2025?
Significant advancements in STD diagnostics are a notable trend in the STD diagnostic market. Leading companies are modernizing their testing capabilities and methods to supply a more efficient and quicker diagnosis of sexually transmitted diseases. For example, In May 2022, BD (Becton, Dickinson, and Company), a medical technology firm based in the United States, introduced a fully automated, high-throughput platform for infectious disease molecular diagnostics, called BD CORTM MX/PX System. This platform integrates and automates the molecular laboratory process, from sample processing to the delivery of diagnostic test outcomes. The inaugural test that's available on this revolutionary platform is the BD CTGCTV2 molecular assay, a single test capable of identifying the three most prevalent non-viral STIs: Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC), and Trichomonas vaginalis (TV).

What Are the Emerging Segments in the STD Diagnostics Market?
The std diagnostics market covered in this report is segmented -

1) By Type: Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Testing, Other Types
2) By Location Of Testing: Laboratory Testing, Point Of Care (PoC) Testing
3) By End-User: Hospitals And Clinics, Diagnostic Centers, Homecare

Subsegments:
1) By Chlamydia Testing: Nucleic Acid Amplification Tests (NAAT), Antigen Tests
2) By Syphilis Testing: Rapid Plasma Reagin (RPR) Tests, Treponemal Tests
3) By Gonorrhea Testing: Nucleic Acid Amplification Tests (NAAT), Culture Tests
4) By Herpes Simplex Virus Testing: PCR Tests, Serological Tests
5) By Human Papilloma Virus Testing: HPV DNA Tests, HPV RNA Tests
6) By Human Immunodeficiency Virus Testing: Antibody Tests, Antigen Or Antibody Tests, Nucleic Acid Tests (NAT)
7) By Chancroid Testing: Culture Tests, Nucleic Acid Tests
8) By Other Types: Various Emerging Tests

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8507&type=smp

Who Are the Global Leaders in the STD Diagnostics Market?
Major companies operating in the STD diagnostics market are Siemens AG, Abbott Laboratories, Qiagen Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Bio-Rad Laboratories Inc., Becton Dickinson and Company, Thermo Fisher Scientific Inc., Biocartis NV, Trinity Biotech PLC, Binx Health Inc., NOWDiagnostics Inc., Atlas Genetics Ltd., BioFire Diagnostics LLC, BioMérieux SA, Chembio Diagnostic Systems Inc., Corgenix Medical Corporation, Creative Diagnostics, Curetis AG, Daktari Diagnostics, Enzo Biochem Inc., Fujirebio Diagnostics Inc., GenePOC Inc., GenMark Diagnostics Inc., Grifols Diagnostic Solutions Inc., Hain Lifescience GmbH, InDevR Inc., Karius Inc., Luminex Corporation, Meridian Bioscience Inc., Mesa Biotech Inc., Mobidiag Oy

Which are the Top Profitable Regional Markets for the STD Diagnostics Industry?
North America was the largest region in the STD diagnostics market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the STD diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8507

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.